Klp Kapitalforvaltning As Crispr Therapeutics Ag Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 16,100 shares of CRSP stock, worth $700,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,100Holding current value
$700,189% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
60.3MCall Options Held
1.26MPut Options Held
1.81M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$390 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$380 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$130 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$121 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$119 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.39B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....